| Role of NOX2-derived reactive oxygen species in NK cell–mediated control of murine melanoma metastasis E Aydin, J Johansson, FH Nazir, K Hellstrand, A Martner Cancer immunology research 5 (9), 804-811, 2017 | 103 | 2017 |
| NOX2 in autoimmunity, tumor growth and metastasis A Martner, E Aydin, K Hellstrand The Journal of pathology 247 (2), 151-154, 2019 | 55 | 2019 |
| Histamine promotes the development of monocyte-derived dendritic cells and reduces tumor growth by targeting the myeloid NADPH oxidase A Martner, HG Wiktorin, B Lenox, FE Sander, E Aydin, J Aurelius, ... The Journal of Immunology 194 (10), 5014-5021, 2015 | 48 | 2015 |
| NOX2-Derived Reactive Oxygen Species in Cancer H Grauers Wiktorin, E Aydin, K Hellstrand, A Martner Oxidative Medicine and Cellular Longevity 2020, 2020 | 42 | 2020 |
| Anti-leukemic properties of histamine in monocytic leukemia: the role of NOX2 R Kiffin, H Grauers Wiktorin, MS Nilsson, J Aurelius, E Aydin, B Lenox, ... Frontiers in oncology 8, 218, 2018 | 30 | 2018 |
| NOX2 inhibition reduces oxidative stress and prolongs survival in murine KRAS-induced myeloproliferative disease E Aydin, A Hallner, HG Wiktorin, A Staffas, K Hellstrand, A Martner Oncogene 38 (9), 1534-1543, 2019 | 29 | 2019 |
| Phosphoinositide 3-Kinase Signaling in the Tumor Microenvironment: What Do We Need to Consider When Treating Chronic Lymphocytic Leukemia With PI3K Inhibitors? E Aydin, S Faehling, M Saleh, LL Cid, M Seiffert, PM Roessner Frontiers in Immunology 11, 2020 | 14 | 2020 |
| Cytomegalovirus serostatus affects autoreactive NK cells and outcomes of IL2-based immunotherapy in acute myeloid leukemia E Bernson, A Hallner, FE Sander, M Nicklasson, MS Nilsson, ... Cancer immunology research 6 (9), 1110-1119, 2018 | 12 | 2018 |
| Role of NOX2 for leukaemic expansion in a murine model of BCR‐ABL1+ leukaemia H Grauers Wiktorin, T Nilsson, E Aydin, K Hellstrand, L Palmqvist, ... British journal of haematology 182 (2), 290-294, 2018 | 12 | 2018 |
| A hypomorphic Cbx3 allele causes prenatal growth restriction and perinatal energy homeostasis defects E Aydin, DP Kloos, E Gay, W Jonker, L Hu, J Bullwinkel, JP Brown, ... Journal of biosciences 40 (2), 325-338, 2015 | 12 | 2015 |
| Idelalisib rescues natural killer cells from monocyte-induced immunosuppression by inhibiting NOX2-derived reactive oxygen species AA Akhiani, A Hallner, R Kiffin, E Aydin, O Werlenius, J Aurelius, ... Cancer Immunology Research 8 (12), 1532-1541, 2020 | 11 | 2020 |
| Isolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit metastasis J Johansson, R Kiffin, E Aydin, MS Nilsson, K Hellstrand, P Lindnér, ... OncoImmunology, 1684126, 2019 | 7 | 2019 |
| PI3K signaling in the tumor microenvironment: What needs to be considered when treating CLL with PI3K inhibitors? E Aydin, S Faehling, MMS Saleh, L Llao Cid, M Seiffert, PM Roessner Frontiers in Immunology 11, 3583, 2020 | | 2020 |
| NOX2 inhibition reduces oxidative stress and prolongs survival of mice with Kras induced myeloproliferative disease E Aydin, A Hallner, HG Wiktorin, A Staffas, K Hellstrand, A Martner Cancer Research 78 (13 Supplement), 441-441, 2018 | | 2018 |
| Targeting NOX2 in cancer E Aydin | | 2018 |
| Delayed Expansion of Murine BCR-ABL1+ Leukemia By Genetic and Pharmacological Inhibition of NOX2 H Grauers Wiktorin, M Nilsson, T Nilsson, J Gustafsson, E Aydin, ... Blood 130 (Supplement 1), 2879-2879, 2017 | | 2017 |
| Anti-Leukemic Properties of Histamine in Monocytic Leukemia: Role of NOX2 R Kiffin, H Grauers Wiktorin, M Nilsson, J Aurelius, E Aydin, B Lenox, ... Blood 130 (Supplement 1), 3818-3818, 2017 | | 2017 |
| Histamine targets the NADPH oxidase/NOX2 to reduce B16F10 melanoma metastasis in mice E Aydin, F Nazir, K Hellstrand, A Martner Pigment Cell & Melanoma Research 28 (6), 2015 | | 2015 |
| HISTAMINE PROMOTES THE DIFFERENTIATION OF DENDRITIC CELLS AND REDUCES TUMOR GROWTH BY TARGETING THE MYELOID NADPH OXIDASE A Martner, B Lenox, HG Wiktorin, J Aurelius, F Ewald, E Aydin, FB Thoren, ... ANTICANCER RESEARCH 34 (10), 6051-6052, 2014 | | 2014 |
| CIR-16-0382R [Martner] E Aydin, J Johansson, FH Nazir, K Hellstrand | | |
